School Of Medicine Basic Sciences

The School of Medicine Basic Sciences is a remarkable community dedicated to advancing the study of human biology, health, and disease. In addition to the award-winning faculty, postdocs, and students who are at the forefront of our cutting-edge research, a large part of our school’s success can be attributed to… Read More

National Cancer Institute molecular biologist André Nussenzweig delivered a School of Medicine Basic Sciences Apex Lecture on Dec. 15 about genome stability in mitotic and post-mitotic cells. Read More

As 2025 draws to a close, we reflect on the achievements and contributions to science made by the School of Medicine Basic Sciences community over the past year. SOMBS facilitates outstanding fundamental science research across four departments, two institutes, 10 centers, and 18 core facilities. The work of our faculty,… Read More

Hannah Collins was named the 2025 Destination Biochemistry Stanley Cohen Postdoctoral Scholar in recognition of her exceptional training, innovative research on microglial signaling, and strong potential as a future scientific leader. Joining Bruce Carter’s lab, she brings significant expertise and new perspectives to studies of the Jedi receptor in microglial function. Read More

The U.S. Food and Drug Administration has approved the use of the new antibiotic gepotidacin for use against uncomplicated gonorrhea. The biochemistry lab of Neil Osheroff provided all mechanism of action data in the FDA application. Read More

Laboratory of Genome Integrity chief André Nussenzweig will present the Vanderbilt School of Medicine Basic Sciences Apex Lecture on Monday, Dec. 25, 2025. Read More

With novel insights in understanding and treating substance use disorder that have redirected neuropsychopharmacological dogma, Erin Calipari receives award from the American College of Neuropsychopharmacology. Read More

Meet Katherine Clowes Moster, a trainee in the lab of Chuck Sanders in the Department of Biochemistry. Read More

For our latest Alum Answers feature, meet Dave Vigerust, PhD’04, who trained as a scientist in Vanderbilt’s IGP umbrella program and then in the Cellular and Molecular Pathology program. He has spent his career interfacing between basic research and the clinic and is now the chief scientific and strategy officer of three companies. Read More

Long-time collaborators and friends Chuck Sanders and Dr. Al George sat down for a Thanksgiving conversation focused on fainting goats, sacred cows, and disordered muscles in humans. Read More